Clinical characteristics and prognosis of patients with idiopathic membranous nephropathy with kidney tubulointerstitial damage

References

• Suryawanshi M, Karnik S, Roy S. Clinicopathological analysis of glomerular disease of adult onset nephrotic syndrome in an Indian cohort–a retrospective study. J Clin Diagn Res. 2017;11(1):1–10.
   Google Scholar
• Ronco P, Debiec H. Pathophysiological advances in membranous nephropathy: time for a shift in patient’s care. Lancet. 2015;385(9981):1983–1992.
   PubMed Web of Science ®Google Scholar
• Couser WG. Primary membranous nephropathy. Clin J Am Soc Nephrol. 2017;12(6):983–997.
   PubMed Web of Science ®Google Scholar
• Obrisca B, Ismail G, Jurubita R, et al. Antiphospholipase A2 receptor autoantibodies: a step forward in the management of primary membranous nephropathy. Biomed Res Int. 2015;2015:249740.
   PubMed Web of Science ®Google Scholar
• Polanco N, Gutierrez E, Covarsi A, et al. Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. J Am Soc Nephrol. 2010;21(4):697–704.
   PubMed Web of Science ®Google Scholar
• Chen Y, Tang L, Feng Z, et al. Pathological predictors of renal outcomes in nephrotic idiopathic membranous nephropathy with decreased renal function. J Nephrol. 2014;27(3):307–316.
   PubMed Web of Science ®Google Scholar
• Ehrenreich T, Churg J. Pathology of membranous nephropathy. Pathol Ann. 1968;3:145–154.
   Google Scholar
• Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Inter. 2012;Suppl 2:139–274.
   Web of Science ®Google Scholar
• Ichimura T, Bonventre JV, Bailly V, et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem. 1998;273(7):4135–4142.
   PubMed Web of Science ®Google Scholar
• Guo W, Diao Z, Liu W. Analysis on clinical characteristics of primary membranous nephropathy complicated with renal tubular interstitial impairment. J Clin Exp Med. 2019;18(6):598–601.
   Google Scholar
• Kumar V, Varma AK, Nada R, et al. Primary membranous nephropathy in adolescence: a prospective study. Nephrology. 2017;22(9):678–683.
   PubMed Web of Science ®Google Scholar
• Jha V, Ganguli A, Saha TK, et al. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. J Am Soc Nephrol. 2007;18(6)​:1899–1904.
   PubMed Web of Science ®Google Scholar
• Gupta R, Sharma A, Mahanta PJ, et al. Focal segmental glomerulosclerosis in idiopathic membranous glomerulonephritis: a clinico-pathological and stereological study. Nephrol Dial Transplant. 2010;25(2):444–449.
   PubMed Web of Science ®Google Scholar
• Zhang BO, Cheng M, Yang M, et al. Analysis of the prognostic risk factors of idiopathic membranous nephropathy using a new surrogate end point. Biomed Rep. 2016;4(2):147–152.
   PubMed Web of Science ®Google Scholar
• Troyanov S, Wall CA, Miller JA, et al. Idiopathic membranous nephropathy: definition and relevance of a partial remission. Kidney Int. 2004;66(3):1199–1205.
   PubMed Web of Science ®Google Scholar
• Laluck BJ, Cattran DC. Prognosis after a complete remission in adult patients with idiopathic membranous nephropathy. Am J Kidney Dis. 1999;33(6):1026–1032.
   PubMed Web of Science ®Google Scholar
• Feutren G, Mihatsch MJ. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International kidney biopsy registry of cyclosporine in autoimmune diseases. N Engl J Med. 1992;326(25):1654–1660.
   PubMed Web of Science ®Google Scholar
• Xu J, Zhang W, Xu Y, et al. Tacrolimus combined with corticosteroids in idiopathic membranous nephropathy: a randomized, prospective, controlled trial. Contrib Nephrol. 2013;181:152–162.
   PubMed Web of Science ®Google Scholar
• Zuo K, Wu Y, Li SJ, et al. Long-term outcome and prognostic factors of idiopathic membranous nephropathy in the Chinese population. Clin Nephrol. 2013;79(6):445–453.
   PubMed Web of Science ®Google Scholar
• Shiiki H, Saito T, Nishitani Y, et al. Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int. 2004;65(4):1400–1407.
   PubMed Web of Science ®Google Scholar
• Risdon RA, Sloper JC, De Wardener HE. Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet. 1968;2(7564):363–366.
   PubMed Web of Science ®Google Scholar
• Bohle A, Christ H, Grund KE, et al. The role of the interstitium of the renal cortex in renal disease. Contrib Nephrol. 1979;16:109–114.
   PubMedGoogle Scholar
• Mackensen-Haen S, Bader R, Grund KE, et al. Correlations between renal cortical interstitial fibrosis, atrophy of the proximal tubules and impairment of the glomerular filtration rate. Clin Nephrol. 1981;15(4):167–171.
   PubMed Web of Science ®Google Scholar
• Cheng W, Sun L, Dong H, et al. Clinicopathologic characteristic and prognosis in idiopathic membranous nephropathy patients with focal segmental sclerosis lesion: a retrospective observational study. Medicine. 2021;100(3):e23988.
   PubMed Web of Science ®Google Scholar
• Li J, Chen B, Gao C, et al. Clinical and pathological features of idiopathic membranous nephropathy with focal segmental sclerosis. BMC Nephrol. 2019;20(1):467. Published 2019 Dec 16.
   PubMed Web of Science ®Google Scholar
• Guo W, Zhang Y, Gao C, et al. Retrospective study: clinicopathological features and prognosis of idiopathic membranous nephropathy with seronegative anti-phospholipase A2 receptor antibody. PeerJ. 2020;8:e8650.
   PubMed Web of Science ®Google Scholar
• Liu BC, Tang TT, Lv LL, et al. Renal tubule injury: a driving force toward chronic kidney disease. Kidney Int. 2018;93(3):568–579.
   PubMed Web of Science ®Google Scholar
• Hofstra JM, Beck LHJr, Beck DM, et al. Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol. 2011;6(6):1286–1291.
   PubMed Web of Science ®Google Scholar
• An CJ, Akankwasa G, Liu JH, et al. Urine markers of renal tubular injury in idiopathic membranous nephropathy: a cross sectional study. Clin Chim Acta. 2019;492:7–11.
   PubMed Web of Science ®Google Scholar